Russell Investments Group
TNGX icon

Russell Investments Group’s Tango Therapeutics TNGX Stock Holding History

Russell Investments Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.8M Buy
281,633
+268,793
+2,093% +$6.65M 0.01% 1146
2026
Q1 		$269K Buy
12,840
+3,046
+31% +$42.4K ﹤0.01% 2749
2025
Q4 		$86.8K Buy
9,794
+2,065
+27% +$17.8K ﹤0.01% 3091
2025
Q3 		$64.9K Buy
7,729
+6,352
+461% +$43K ﹤0.01% 3176
2025
Q2 		$7.05K Sell
1,377
-49,806
-97% -$123K ﹤0.01% 3393
2025
Q1 		$72.9K Buy
51,183
+49,116
+2,376% +$121K ﹤0.01% 2828
2024
Q4 		$6.39K Buy
2,067
+1,998
+2,896% +$9.28K ﹤0.01% 3230
2024
Q3 		$531 Buy
69
+38
+123% +$363 ﹤0.01% 3569
2024
Q2 		$266 Hold
31
– – ﹤0.01% 3538
2024
Q1 		$246 Hold
31
– – ﹤0.01% 3266
2023
Q4 		$307 Hold
31
– – ﹤0.01% 3154
2023
Q3 		$349 Sell
31
-34,412
-100% -$210K ﹤0.01% 3434
2023
Q2 		$114K Buy
+34,443
New +$124K ﹤0.01% 2583

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Russell Investments Group's TNGX Position: Q2 2026 in Review

Russell Investments Group increased its Tango Therapeutics (TNGX) stake by 2,093% in Q2 2026, buying an estimated $6.65M and bringing the position to 281,633 shares worth $8.8M. The position accounts for 0.01% of the portfolio, ranked #1146.

Russell Investments Group first reported a position in TNGX in Q2 2023 and has held it in 13 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Russell Investments Group held 281,633 shares of Tango Therapeutics worth $8.8M as of Q2 2026.
  • Russell Investments Group bought 268,793 Tango Therapeutics shares in Q2 2026, an estimated $6.65M.
  • Tango Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1146 holding.
  • Russell Investments Group first reported a position in Tango Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.